Ozantürk Ayşegül, Marshall Jan D, Collin Gayle B, Düzenli Selma, Marshall Robert P, Candan Şükrü, Tos Tülay, Esen İhsan, Taşkesen Mustafa, Çayır Atilla, Öztürk Şükrü, Üstün İhsan, Ataman Esra, Karaca Emin, Özdemir Taha Reşid, Erol İlknur, Eroğlu Fehime Kara, Torun Deniz, Parıltay Erhan, Yılmaz-Güleç Elif, Karaca Ender, Atabek M Emre, Elçioğlu Nursel, Satman İlhan, Möller Claes, Muller Jean, Naggert Jürgen K, Özgül Rıza Köksal
Institute of Child Health and Metabolism Unit, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
The Jackson Laboratory, Bar Harbor, ME, USA.
J Hum Genet. 2015 Jan;60(1):1-9. doi: 10.1038/jhg.2014.85. Epub 2014 Oct 9.
Alström syndrome (ALMS) is an autosomal recessive disease characterized by multiple organ involvement, including neurosensory vision and hearing loss, childhood obesity, diabetes mellitus, cardiomyopathy, hypogonadism, and pulmonary, hepatic, renal failure and systemic fibrosis. Alström Syndrome is caused by mutations in ALMS1, and ALMS1 protein is thought to have a role in microtubule organization, intraflagellar transport, endosome recycling and cell cycle regulation. Here, we report extensive phenotypic and genetic analysis of a large cohort of Turkish patients with ALMS. We evaluated 61 Turkish patients, including 11 previously reported, for both clinical spectrum and mutations in ALMS1. To reveal the molecular diagnosis of the patients, different approaches were used in combination, a cohort of patients were screened by the gene array to detect the common mutations in ALMS1 gene, then in patients having any of the common ALMS1 mutations were subjected to direct DNA sequencing or next-generation sequencing for the screening of mutations in all coding regions of the gene. In total, 20 distinct disease-causing nucleotide changes in ALMS1 have been identified, eight of which are novel, thereby increasing the reported ALMS1 mutations by 6% (8/120). Five disease-causing variants were identified in more than one kindred, but most of the alleles were unique to each single patient and identified only once (16/20). So far, 16 mutations identified were specific to the Turkish population, and four have also been reported in other ethnicities. In addition, 49 variants of uncertain pathogenicity were noted, and four of these were very rare and probably or likely deleterious according to in silico mutation prediction analyses. ALMS has a relatively high incidence in Turkey and the present study shows that the ALMS1 mutations are largely heterogeneous; thus, these data from a particular population may provide a unique source for the identification of additional mutations underlying Alström Syndrome and contribute to genotype-phenotype correlation studies.
阿尔斯特伦综合征(ALMS)是一种常染色体隐性疾病,其特征是多器官受累,包括神经感觉性视力和听力丧失、儿童肥胖、糖尿病、心肌病、性腺功能减退以及肺、肝、肾衰竭和全身纤维化。阿尔斯特伦综合征由ALMS1基因突变引起,并且人们认为ALMS1蛋白在微管组织、鞭毛内运输、内体再循环和细胞周期调控中发挥作用。在此,我们报告了对一大群土耳其ALMS患者进行的广泛表型和基因分析。我们评估了61名土耳其患者,包括11名先前报告过的患者,以了解其临床谱和ALMS1基因突变情况。为了揭示患者的分子诊断,我们联合使用了不同方法,一组患者通过基因阵列进行筛查以检测ALMS1基因中的常见突变,然后对具有任何常见ALMS1突变的患者进行直接DNA测序或下一代测序,以筛查该基因所有编码区域中的突变。总共在ALMS1中鉴定出20种不同的致病核苷酸变化,其中8种是新发现的,从而使报告的ALMS1突变增加了6%(8/120)。在不止一个家族中鉴定出5种致病变体,但大多数等位基因在每个患者中都是独特的,且仅被鉴定过一次(16/20)。到目前为止,鉴定出的16种突变是土耳其人群特有的,其中4种在其他种族中也有报告。此外,还发现了49种致病性不确定的变体,根据计算机模拟突变预测分析,其中4种非常罕见,可能或很可能具有有害性。ALMS在土耳其的发病率相对较高,本研究表明ALMS1突变在很大程度上具有异质性;因此,来自特定人群的这些数据可能为鉴定阿尔斯特伦综合征潜在的其他突变提供独特来源,并有助于基因型-表型相关性研究。